These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38396680)

  • 21. VSDMIP 1.5: an automated structure- and ligand-based virtual screening platform with a PyMOL graphical user interface.
    Cabrera ÁC; Gil-Redondo R; Perona A; Gago F; Morreale A
    J Comput Aided Mol Des; 2011 Sep; 25(9):813-24. PubMed ID: 21826555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TNT version 1.6, with a graphical interface for MacOS and Linux, including new routines in parallel.
    Goloboff PA; Morales ME
    Cladistics; 2023 Apr; 39(2):144-153. PubMed ID: 36682054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A cluster-aware graphical user interface for a virtual ligand screening tool.
    Ramjan ZH; Raheja A; Floriano WB
    Annu Int Conf IEEE Eng Med Biol Soc; 2008; 2008():4102-5. PubMed ID: 19163614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AMDock: a versatile graphical tool for assisting molecular docking with Autodock Vina and Autodock4.
    Valdés-Tresanco MS; Valdés-Tresanco ME; Valiente PA; Moreno E
    Biol Direct; 2020 Sep; 15(1):12. PubMed ID: 32938494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DD-GUI: a graphical user interface for deep learning-accelerated virtual screening of large chemical libraries (Deep Docking).
    Yaacoub JC; Gleave J; Gentile F; Stern A; Cherkasov A
    Bioinformatics; 2022 Jan; 38(4):1146-1148. PubMed ID: 34788802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MAGI-Dock: a PyMOL companion to Autodock Vina.
    Kaftalli J; Bernini A; Bonetti G; Cristoni S; Marceddu G; Bertelli M
    Eur Rev Med Pharmacol Sci; 2023 Dec; 27(6 Suppl):148-151. PubMed ID: 38112955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In silico identification and evaluation of leads for the simultaneous inhibition of protease and helicase activities of HCV NS3/4A protease using complex based pharmacophore mapping and virtual screening.
    Wadood A; Riaz M; Uddin R; Ul-Haq Z
    PLoS One; 2014; 9(2):e89109. PubMed ID: 24551230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LiGRO: a graphical user interface for protein-ligand molecular dynamics.
    Kagami LP; das Neves GM; da Silva AWS; Caceres RA; Kawano DF; Eifler-Lima VL
    J Mol Model; 2017 Oct; 23(11):304. PubMed ID: 28980073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FINDSITE(comb): a threading/structure-based, proteomic-scale virtual ligand screening approach.
    Zhou H; Skolnick J
    J Chem Inf Model; 2013 Jan; 53(1):230-40. PubMed ID: 23240691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-based virtual screening of the nociceptin receptor: hybrid docking and shape-based approaches for improved hit identification.
    Daga PR; Polgar WE; Zaveri NT
    J Chem Inf Model; 2014 Oct; 54(10):2732-43. PubMed ID: 25148595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computer-aided drug design platform using PyMOL.
    Lill MA; Danielson ML
    J Comput Aided Mol Des; 2011 Jan; 25(1):13-9. PubMed ID: 21053052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dockey: a modern integrated tool for large-scale molecular docking and virtual screening.
    Du L; Geng C; Zeng Q; Huang T; Tang J; Chu Y; Zhao K
    Brief Bioinform; 2023 Mar; 24(2):. PubMed ID: 36764832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MEPHAS: an interactive graphical user interface for medical and pharmaceutical statistical analysis with R and Shiny.
    Zhou Y; Leung SW; Mizutani S; Takagi T; Tian YS
    BMC Bioinformatics; 2020 May; 21(1):183. PubMed ID: 32393166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of non-macrocyclic small molecule inhibitors against the NS3/4A serine protease of hepatitis C virus through in silico screening.
    Chaudhuri R; Lee H; Truong L; Torres J; Patel K; Johnson ME
    J Chem Inf Model; 2012 Aug; 52(8):2245-56. PubMed ID: 22697413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LigGrep: a tool for filtering docked poses to improve virtual-screening hit rates.
    Ha EJ; Lwin CT; Durrant JD
    J Cheminform; 2020 Nov; 12(1):69. PubMed ID: 33292486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AutoDock and AutoDockTools for Protein-Ligand Docking: Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1(BACE1) as a Case Study.
    El-Hachem N; Haibe-Kains B; Khalil A; Kobeissy FH; Nemer G
    Methods Mol Biol; 2017; 1598():391-403. PubMed ID: 28508374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Functional and Druggable Sites in
    Thornton BP; Johns A; Al-Shidhani R; Álvarez-Carretero S; Storer ISR; Bromley MJ; Tabernero L
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31546755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PLHINT: A knowledge-driven computational approach based on the intermolecular H bond interactions at the protein-ligand interface from docking solutions.
    Kumar SP
    J Mol Graph Model; 2018 Jan; 79():194-212. PubMed ID: 29241118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of potential inhibitors for HCV NS3 genotype 4a by combining protein-ligand interaction fingerprint, 3D pharmacophore, docking, and dynamic simulation.
    El-Hasab MAE; El-Bastawissy EE; El-Moselhy TF
    J Biomol Struct Dyn; 2018 May; 36(7):1713-1727. PubMed ID: 28531373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Consensus docking: improving the reliability of docking in a virtual screening context.
    Houston DR; Walkinshaw MD
    J Chem Inf Model; 2013 Feb; 53(2):384-90. PubMed ID: 23351099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.